Sector Chart Clinuvel Pharmaceuticals Limited Deutsche Boerse AG
Stocks
UR9
AU000000CUV3
Pharmaceuticals
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.282 EUR | +5.58% |
|
0.00% | -15.00% |
| 06-15 | Clinuvel Pharmaceuticals Advances US Listing Plan With SEC Filing for Nasdaq ADS Upgrade | MT |
| 04-27 | Clinuvel Pharmaceuticals plans level II ADR upgrade and Nasdaq listing as CUVL | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 66.56B | |||||
| 57.64B | |||||
| 42.24B | |||||
| 39.09B | - | ||||
| 31.91B |
Select your edition
All financial news and data tailored to specific country editions
